USD 6.9 billion
Report ID:
SQMIG35B2070 |
Region:
Global |
Published Date: September, 2024
Pages:
260
|Tables:
91
|Figures:
75
Contrast Media Market size was valued at USD 6.9 billion in 2023 and is poised to grow from USD 7.46 billion in 2024 to USD 13.91 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).
Contrast media market is impacted by the growing incidences of chronic diseases, improvements in imaging modalities, and increasing diagnostic imaging procedures. Nonetheless, the market is restrained by factors like concerns for adverse reactions and safety including allergic reactions. Another key restraining factor witnessed in the market includes significantly priced contrast agents, which may impede its adoption in the developing regions. Yet, the market will grow progressively due to improvements in the development of contrast agents, growing integration of technologies, and flourishing markets.
US Contrast Media Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
USD 6.9 billion
Largest Segment
X-ray/CT
Fastest Growth
ultrasound
Growth Rate
8.1% CAGR
To get more reports on the above market click here to Buy The Report
Global Contrast Media Market is segmented by Type, Form, Modality, Route of Administration, Indication, Market, By Application and region. Based on Type, the market is segmented into Iodinated contrast media, Gadolinium-based contrast media, Microbubble contrast media and Barium-based contrast media. Based on Form, the market is segmented into Liquid, Powder and Other forms. Based on Modality, the market is segmented into X-ray, Computed tomography (CT), Magnetic resonance imaging (MRI) and Ultrasound. Based on Route of Administration, the market is segmented into Intravascular route, Oral route, Rectal route and Other routes of administration. Based on Indication, the market is segmented into Cardiovascular disease, Cancer, Gastrointestinal disorders, Musculoskeletal disorders, Neurological disorders and Nephrological disorders. Based on Market, By Application, the market is segmented into Radiology, Interventional radiology, Interventional cardiology, Market, By End User, Hospitals, clinics, and ASCs and Diagnostic imaging center. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Based on modality, the contrast media market is categorized into X-ray, CT, MRI, Ultrasound. The CT or computed tomography segment held a notable share of the market in 2023 and is expected to lead over the forecast period as well owing to its best diagnostic accuracy, mounting demand for emergency imaging widespread availability. Computed tomography scans offer cross-detailed pictures that increases their significance for treating and diagnosing diverse conditions, mainly for internal injuries and cancers. They are widely preferred owing to effectiveness and speed propelling the demand of contrast media. CT equipment are also easily available in clinics and hospitals, thus increasing their accessibility to the large population.
On the other hand, the ultrasound segment is projected to grow considerably over the forecast period owing to its increased preference by patients due to non-invasiveness, real-time imaging, and mounting applications. Ultrasound is painless imaging techniques, due to which it is highly preferred for clinicians and patients. It offers better quality real-time imaging, which is demanded for improved guidance, examinations, and surgeries, mainly in vascular and obstetrics. The growing use of ultrasound in multiple medical domains like oncology, cardiology, and emergency medicine, raises the need for contrast agents.
Based on end user, the market is segmented into hospitals, clinics, and ambulatory surgery centers, diagnostic imaging centers. The hospitals segment held a notable market share in the previous years and is expected to continue dominance over the forecast period as well owing to the increasing patient admissions and availability of comprehensive services and improved technologies. Hospitals manage large patient volume on a daily basis, demanding increased more diagnostic procedures that need contrast media. These setting offer broad range of services like x-ray, MRI, CT scans and more which use contrast agent. They are equipped with latest equipment and technologies, allowing complex procedures that use contrast media, thus driving the segmental growth.
On the other hand, the diagnostic imaging centers segment will hold a notable market share in the forthcoming years owing to the availability and accessibility to improved technologies and growing popularity among outpatients. Since a greater number of individuals are preferring outpatient care, these centers are gaining prominence for routing imaging, impacting the need for contrast agents. Most imaging centers are heavily investing in advanced technologies like CT and MRI equipment, which increases the services range. These diagnostic centers are also more easily accessible than hospitals, offering convenient locations for individuals to obtain imaging facilities, thus driving the segment's growth.
To get detailed analysis on other segments, Request For Free Sample Report
Region-wise, North America dominated the market in the previous years and is expected to lead over the forecast period owing to the presence of advanced healthcare infrastructure, growing demand for diagnostic imaging, and robust research and development. North America brags about its well-developed healthcare infrastructure equipped with superior imaging facilities and technologies. Furthermore, the growing patient volume that demands imaging procedures is notably impacted by the rising cases of chronic diseases and emphasis on early diagnosis. Key biotechnology and pharmaceutical companies are increasing investing in research and development, resulting in advanced and modernized contrast agents. The leading players profiled in the region include GE Healthcare, Lantheus Medical Imaging, Advacare Pharma, Bracco Diagnostics, Bayer, and more.
Asia-Pacific is the fastest-growing region in global contrast media market due to the speedy expansion of healthcare, growing urbanization and population, and increasing disposable income of consumers. Major investments in medical infrastructure and rising accessibility to diverse services and facilities are demanding diagnostic imaging technologies. Speedily growing population and urbanization is also fueling the demand for diagnostic services due to growing cases of chronic illnesses. Moreover, developing economies is resulting in high disposable income, enabling a large patient population to access advanced diagnostic services.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Contrast Media Market Drivers
Growing Acceptance and Awareness
Growing patient awareness regarding the significance of diagnostic imaging in disease management and detection is resulting in growing demand for contrast agents. The market growth is also propelled by the growing healthcare professional advocacy. Medical professionals are largely recognizing the significance and advantages of contrast-enhanced imaging for precise diagnosis and results, resulting in a greater number of prescriptions.
Healthcare Globalization to Fuel Market Growth
Increased mobility and growth of medical tourism are majorly fueling the growth of the contrast media market. Growing globalization of healthcare, comprising cross-border healthcare facilities is resulting in increased demand for developed imaging techniques. This comprises the adoption of contrast media. As more individuals are preferring medical facilities and treatment abroad, the medical tourism is increasing considerably, impacting the use of contrast media.
Contrast Media Market Restraints
Low Awareness in the Developing Regions
In most developing markets, the number of healthcare professionals and availability of improved technologies and facilities may be restricted, which could majorly limit the market growth. There may also be low awareness for the advantages and uses of contrast media, hindering the market growth. lack of training for medical experts for the operation of contrast agents and improved imaging modalities may restrict its adoption.
Alternate Imaging Techniques
Improvements in imaging technologies like magnetic resonance imaging and ultrasound that do not demand contrast agents may also slow down its demand, which may lessen the need for customary contrast media. Moreover, the development of novel diagnostic techniques that are not dependent on contrast agents may be a challenge for the market growth.
Request Free Customization of this report to help us to meet your business objectives.
The global contrast media market is progressing remarkably due to the strengthening competition by prominent players like GE Healthcare, Bracco Imaging S.p.A., Lantheus Medical Imaging, J.B. Chemicals & Pharmaceuticals Limited, and Unijules Life Sciences Ltd. who are engaged in expanding their product portfolio, geographic reach, and investments. The market is witnessing notable improvements in imaging technologies supported by efforts by new product developments, and collaborations and strategic partnerships. Overall, focus on enhancing imaging quality and patient outcomes will transform the competitive landscape in the future.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the contrast media market is considerably progressing due to the growing innovations in contrast agents like introduction of safe and non-ionic agents, rising number of strategic acquisitions and alliances, and simplified standards and approvals. However, the market is restrained by the challenges associated with logistics, growing environmental concerns, and patient factors like patient refusal due to concerns for adverse effects. North America is anticipated to lead the market owing to improved healthcare infrastructure, supportive regulatory environment, and robust research and development. Nonetheless, a few opportunities for the growth of the contrast media market include increasing education and awareness, emphasis on management of chronic diseases, and heavy integration of telemedicine.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 6.9 billion |
Market size value in 2032 | USD 13.91 billion |
Growth Rate | 8.1% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Contrast Media Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Contrast Media Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Contrast Media Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Contrast Media Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
Contrast Media Market size was valued at USD 6.55 Billion in 2023 and is poised to grow from USD 7.03 Billion in 2024 to USD 12.46 Billion by 2032, growing at a CAGR of 7.4% during the forecast period (2025-2032).
The global contrast media market is progressing remarkably due to the strengthening competition by prominent players like GE Healthcare, Bracco Imaging S.p.A., Lantheus Medical Imaging, J.B. Chemicals & Pharmaceuticals Limited, and Unijules Life Sciences Ltd. who are engaged in expanding their product portfolio, geographic reach, and investments. The market is witnessing notable improvements in imaging technologies supported by efforts by new product developments, and collaborations and strategic partnerships. Overall, focus on enhancing imaging quality and patient outcomes will transform the competitive landscape in the future. 'GE Healthcare (US) ', 'Bracco Imaging S.p.A. (Italy) ', 'Bayer AG (Germany) ', 'Guerbet (France) ', 'Lantheus Medical Imaging (US) ', 'Unijules Life Sciences Ltd. (India) ', 'J.B. Chemicals & Pharmaceuticals Limited (India) ', 'Taejoon Pharm Co., Ltd. (South Korea) ', 'Jodas Expoim (India) ', 'Imax Diagnostic Imaging Limited (Ireland) ', 'Yangtze River Pharmaceutical Group (China) ', 'Livealth Biopharma (India) ', 'Beijing Beilu Pharmaceutical Co., Ltd. (China) ', 'Unispire Biopharma Private Limited (India) ', 'Arco Lifesciences (I) Pvt. Ltd. (India) ', 'Stanex Drugs & Chemicals Pvt. Ltd. (India) ', 'Rege Imaging & Cine Films Private Limited (India) ', 'K Diam Exim (India) ', 'Onko Ilaç San. ve Tic. A.S. (Turkey) ', 'Fresenius Kabi (Germany) ', 'Biem Ilaç San. ve Tic. A.S. (Turkey) ', 'Advacare Pharma (US)'
Growing patient awareness regarding the significance of diagnostic imaging in disease management and detection is resulting in growing demand for contrast agents. The market growth is also propelled by the growing healthcare professional advocacy. Medical professionals are largely recognizing the significance and advantages of contrast-enhanced imaging for precise diagnosis and results, resulting in a greater number of prescriptions.
Improved Safety Profiles: The current research and studies in gadolinium contrast agents has emphasized on lowering the threat of NSF (nephrogenic systemic fibrosis) and associated ill-effects. The novel agents that contain comparatively less gadolinium retention and enhanced safe profiles, are increasingly being preferred and developed. Also, non-ionic low osmolar are majorly being used in computed tomography to reduce side-effects, mainly in individuals with renal function issues.
Region-wise, North America dominated the market in the previous years and is expected to lead over the forecast period owing to the presence of advanced healthcare infrastructure, growing demand for diagnostic imaging, and robust research and development. North America brags about its well-developed healthcare infrastructure equipped with superior imaging facilities and technologies. Furthermore, the growing patient volume that demands imaging procedures is notably impacted by the rising cases of chronic diseases and emphasis on early diagnosis. Key biotechnology and pharmaceutical companies are increasing investing in research and development, resulting in advanced and modernized contrast agents. The leading players profiled in the region include GE Healthcare, Lantheus Medical Imaging, Advacare Pharma, Bracco Diagnostics, Bayer, and more.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35B2070
[email protected]
USA +1 351-333-4748